Skip to main content
SpringerLink
Log in

Treatment of Apnea of Prematurity

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

In the last decade, knowledge regarding the neurodevelopment and functional aspects of the respiratory centers during postnatal maturation has increased substantially. However, an increase in such knowledge has not provided a basis for change in practice. The diagnosis of apnea of prematurity (AOP) is one of exclusion. All causes of secondary apnea must be ruled out before initiating treatment for AOP. Treatment will depend on the etiology as well as effectiveness and tolerability of the treatment by the patient. The primary goal of any treatment of AOP is to prevent the frequency of apnea lasting > 20 seconds, and/or those that are shorter, but associated with cyanosis and bradycardia.

The clinical management of AOP is not much different today than it was two decades ago, with pharmacologic and nonpharmacologic treatment options remaining the mainstay of therapy. Methylxanthines are still the most widely used pharmacologic agents. Due to the wider therapeutic index of caffeine and ease of once daily administration, it should be the preferred agent. Doxapram, or nonpharmacologic treatment measures such as nasal continuous positive airway pressure, may be considered in infants who are unresponsive to methylxanthine treatment alone. Treatment should be continued until there is complete resolution of apnea, and for some time thereafter. The choice of method for weaning treatment remains one of individual physician preference. Discharge from hospital after apnea requires close monitoring and some infants will require home apnea monitors. The decision to provide a home apnea monitor should be individualized for each patient, depending on the effectiveness of treatment and clinical response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV

Similar content being viewed by others

References

  1. Cheung PY, Barrington KJ, Finer NN, et al. Early childhood neurodevelopment in very low birth weight infants with predischarge apnea. Pediatr Pulmonol 1999; 27: 14–20

    Article  PubMed  CAS  Google Scholar 

  2. Marchal F, Bairam A, Vert P. Neonatal apnea and apneic syndromes. Clin Perinatol 1987; 14: 509–29

    PubMed  CAS  Google Scholar 

  3. Adams JA, Zabaleta IA, Sackner MA. Hypoxic events in spontaneously breathing premature infants: etiologic basis. Pediatr Res 1997; 42: 463–71

    Article  PubMed  CAS  Google Scholar 

  4. Task Force on Prolonged Infantile Apnea, American Academy of Pediatrics. Prolonged infantile apnea: 1985. Pediatrics 1985; 76: 129–31

    Google Scholar 

  5. Jenni OG, Wolf M, Hengartner M, et al. Impact of central, obstructive and mixed apneas on cerebral hemodynamics in preterm infants. Biol Neonate 1996; 70: 91–100

    Article  PubMed  CAS  Google Scholar 

  6. Perlman J, Volpe J. Episodes of apneoa and bradycardia in the preterm newborn: impact on cerebral circulation. Pediatrics 1985; 76: 333–8

    PubMed  CAS  Google Scholar 

  7. Poets CF, Samuels MP, Southhall DP. Epidemiology and pathophysiology of apnoea of prematurity. Biol Neonate 1994; 65: 211–9

    Article  PubMed  CAS  Google Scholar 

  8. Idiong N, Lemke RP, Lin YJ, et al. Airway closure during mixed apneas in preterm infants: is effort necessary. J Pediatr 1998; 133: 509–12

    Article  PubMed  CAS  Google Scholar 

  9. Henderson-Smart DJ, Pettigrew AG, Campbell DJ. Clinical apnoea and brainstem neural function in preterm infants. N Engl J Med 1983; 308: 353–7

    Article  PubMed  CAS  Google Scholar 

  10. Martin RJ, Miller MJ, Waldemar A, et al. Pathogenesis of apnea in preterm infants. J Pediatr 1986; 109: 733–41

    Article  PubMed  CAS  Google Scholar 

  11. Bolivar JM, Gerhardt T, Gonzalez A, et al. Mechanisms for episodes of hypoxemia in preterm infants undergoing mechanical ventilation. J Pediatr 1995; 127: 767–73

    Article  PubMed  CAS  Google Scholar 

  12. Poets C, Valerie A, Stebbens MP, et al. The relationship between bradycardia, apnea and hypoxemia in preterm infants. Pediatr Res 1993; 34: 144–7

    Article  PubMed  CAS  Google Scholar 

  13. Martin RJ, DiFiore JM, Jana L, et al. Persistence of the biphasic ventilatory response to hypoxia in preterm infants. J Pediatr 1998; 132: 960–4

    Article  PubMed  CAS  Google Scholar 

  14. Alden ER, Mandelkorn R, Woodrum DE, et al. Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery. Pediatrics 1972; 50: 40–9

    PubMed  CAS  Google Scholar 

  15. Henderson-Smart DJ. The effects of gestational age on the incidence and duration of recurrent apnea in newborn babies. Aust Paediatr J 1981; 17: 273–6

    PubMed  CAS  Google Scholar 

  16. Lindgren C, Grogaard J. Reflex apnea response and inflammatory mediators in infants with respiratory tract infection. Acta Paediatr 1996; 85: 798–803

    Article  PubMed  CAS  Google Scholar 

  17. Saxena A, Sharma M, Kothari SS, et al. Prostaglandin E1 in infants with congenital heart disease: the Indian experience. Indian Pediatr 1998; 35: 1063–9

    PubMed  CAS  Google Scholar 

  18. Sheikh S, Stephen TC, Sisson B. Prevalance of gastroesophageal reflux in infants with recurrent brief apneic episodes. Can Respir J 1999; 6: 401–4

    PubMed  CAS  Google Scholar 

  19. Sasidharan P, Heimler R. Transfusion-induced changes in the breathing pattern of healthy preterm anemic infants. Pediatr Pulmonol 1992; 12(3): 170–3

    Article  PubMed  CAS  Google Scholar 

  20. Peter CS, Sprodowski N, Bohnhorst B, et al. Gastroesophageal reflux and apnea of prematurity: no temporal relationship. Pediatrics 2002; 109: 8–11

    Article  PubMed  Google Scholar 

  21. Lagercrantz H. What does the preterm infant breath for: controversies on apnea of prematurity. Acta Paediatr 1992; 81: 733–6

    Article  PubMed  CAS  Google Scholar 

  22. Church MK, Featherstone RL, Cushley MJ, et al. Relationships between adenosine, cyclic nucleotides, and xanthines in asthma. J Allergy Clin Immunol 1986; 78: 670–5

    Article  PubMed  CAS  Google Scholar 

  23. Poison JB, Krzanowski JJ, Goldman AL, et al. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol 1978; 5: 535–9

    Article  Google Scholar 

  24. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991; 46: 512–23

    Article  PubMed  CAS  Google Scholar 

  25. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal. Eur Respir J 1994; 7: 579–91

    Article  PubMed  CAS  Google Scholar 

  26. Gayan-Ramirez G, Janssens S, Himpens B, et al. Mechanism of theophylline-induced inotropic effects on foreshortened canine diaphragm. Eur Respir J 1995; 8: 1915–21

    Article  PubMed  CAS  Google Scholar 

  27. Kolbeck RC, Speir WA. Diltiazem, verapamil and nifedipine inhibit theophylline-enhanced diaphragmatic contractility. Am Rev Respir Dis 1989; 139: 130–45

    Article  Google Scholar 

  28. Gliech GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990; 85: 422–36

    Article  Google Scholar 

  29. Ohta K, Sawamoto S, Nakajima M, et al. The prolonged survival of human eosinophils with interlukine-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 1996; 26Suppl. 2: 10–5

    Article  PubMed  CAS  Google Scholar 

  30. Torphy TJ, Livi GP. Phosphodiesterase isoenzymes in airways. Lung Biol Health Dis 1993; 67: 177–222

    CAS  Google Scholar 

  31. Banner KH, Page CP. Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors. Clin Exp Allergy 1996; 26Suppl. 2: 2–9

    Article  PubMed  CAS  Google Scholar 

  32. Davi MJ, Koravangattu S, Simons KJ, et al. Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. J Pediatr 1978; 92: 91–5

    Article  PubMed  CAS  Google Scholar 

  33. Giacoia G, Jusko WJ, Menke J, et al. Theophylline pharmacokinetics in premature infants with apnea. J Pediatr 1976; 89: 829–32

    Article  PubMed  CAS  Google Scholar 

  34. Hilligoss DM, Jusko WJ, Koup JR, et al. Factors affecting theophylline pharmacokinetics in premature infants with apnea. Dev Pharmacol Ther 1980; 1: 6–15

    PubMed  CAS  Google Scholar 

  35. Latini R, Assael BM, Bonati M, et al. Kinetics and efficacy of theophylline in the treatment of apnea in premature infants. Clin Pharmacol Ther 1978; 13: 203–7

    CAS  Google Scholar 

  36. Neese AL, Soyka LF. Development of a radioimmunoassay for theophylline: application to studies in premature infants. Clin Pharmacol Ther 1977; 21: 633–41

    PubMed  CAS  Google Scholar 

  37. Aranda JV, Sitar DS, Parsons WD, et al. Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 1976; 295: 413–6

    Article  PubMed  CAS  Google Scholar 

  38. Boutroy MJ, Vert P, Royer RJ, et al. Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. J Pediatr 1979; 94: 996–8

    Article  PubMed  CAS  Google Scholar 

  39. du Preeze MJ, Botha JH, McFadyen ML, et al. The pharmacokinetics of theophylline in premature neonates during the first few days after birth. Ther Drug Monit 1999; 21: 598–603

    Article  Google Scholar 

  40. Kraus DM, Fischer JH, Reitz SJ, et al. Alterations in theophylline metabolism during the first year of life. Clin Pharmacol Ther 1993; 54: 351–9

    Article  PubMed  CAS  Google Scholar 

  41. Tateishi T, Asoh M, Yamaguchi A, et al. Developmental changes in urinary elimination of theophylline and its metabolites in pediatric patients. Pediatr Res 1999; 45: 66–70

    Article  PubMed  CAS  Google Scholar 

  42. Houge S, Phelps SJ. Evaluation of three dosing equations for use in infants up to one year of age. J Pediatr 1993; 123: 651–6

    Article  Google Scholar 

  43. Bhatt Mehta V, Donn SM, Schork MA, et al. Prospective evaluation of two dosing equations for theophylline in premature infants. Pharmacotherapy 1996; 16: 769–76

    PubMed  CAS  Google Scholar 

  44. Gorodischer R, Karplus M. Pharmacokinetic aspects of caffeine in premature infants with apnoea. Eur J Clin Pharmacol 1982; 22: 47–52

    Article  PubMed  CAS  Google Scholar 

  45. Pearlman SA, Duran CS, Wood MA, et al. Caffeine pharmacokinetics in preterm infants older than 2 weeks. Dev Pharmacol Ther 1989; 12: 65–9

    PubMed  CAS  Google Scholar 

  46. Aranda JV, Cook CE, Gorman W, et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 1979; 94: 663–8

    Article  PubMed  CAS  Google Scholar 

  47. Aldridge A, Aranda JV, Neims AH. Caffeine metabolism in the newborn. Clin Pharmacol Ther 1979; 25: 447–53

    PubMed  CAS  Google Scholar 

  48. de Carolis MPD, Romagnoli C, Muzii U, et al. Pharmacokinetic aspects of caffeine in premature infants. Dev Pharmacol Ther 1991; 16: 117–22

    PubMed  Google Scholar 

  49. Falcao AC, Gatta MF, Delgado MF, et al. Population pharmacokinetics of caffeine in premature neonates. Eur J Clin Pharmacol 1997; 52: 211–7

    Article  PubMed  CAS  Google Scholar 

  50. Aranda JV, Collinge JM, Zinman R, et al. Maturation of caffeine elimination in infancy. Arch Dis Child 1979; 54: 946–9

    Article  PubMed  CAS  Google Scholar 

  51. Carrier O, Pons G, Rey E, et al. Maturation of caffeine metabolic pathways in infancy. Clin Pharmacol Ther 1988; 44: 145–51

    Article  PubMed  CAS  Google Scholar 

  52. Pons G, Carrier O, Richard M, et al. Developmental changes of caffeine elimination in infancy. Dev Pharmacol Ther 1988; 11: 258–64

    PubMed  CAS  Google Scholar 

  53. Giacoia GP, Jungbluth GL, Jusko WJ. Effect of feeding on oral absorption of caffeine in premature infants. Dev Pharmacol Ther 1989; 12: 205–10

    PubMed  CAS  Google Scholar 

  54. Jamali F, Coutts RT, Malek F, et al. Lack of pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity. Dev Pharmacol Ther 1991; 16: 78–82

    PubMed  CAS  Google Scholar 

  55. Yazdani M, Kissling GE, Tran TH, et al. Phenobarbital increases the theophylline requirement of premature infants being treated for apnea. Am J Dis Child 1987; 141: 97–9

    PubMed  CAS  Google Scholar 

  56. Somani SM, Khanna NN, Bada HS. Caffeine and theophylline: serum/CSF correlation in premature infants. J Pediatr 1980; 96: 1091–3

    Article  PubMed  CAS  Google Scholar 

  57. Turmen T, Davis J, Aranda JV. Relationship of dose and plasma concentrations of caffeine and ventilation in neonatal apnea. Semin Perinatol 1981; 5: 326–31

    PubMed  CAS  Google Scholar 

  58. Aranda JV, Scalias E, Papageorgiou A, et al. Ontogeny of human caffeine and theophylline metabolism. Dev Pharmacol Ther 1984; 7: 18–25

    PubMed  CAS  Google Scholar 

  59. Brazier JL, Sale B, Ribon B, et al. In vivo N7 methylation of theophylline to caffeine in premature infants. Dev Pharmacol Ther 1981; 2: 137–44

    PubMed  CAS  Google Scholar 

  60. Bory C, Baltassat P, Porthault M, et al. Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr 1979; 94: 988–93

    Article  PubMed  CAS  Google Scholar 

  61. Bada H, Khanna NN, Somani SM, et al. Interconversion of theophylline and caffeine in newborn infants. J Pediatr 1979; 94: 993–5

    Article  PubMed  CAS  Google Scholar 

  62. Lin JC, Strauss RG, Kulhavy JC, et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 2000; 106: El9

    Article  Google Scholar 

  63. Blanchette VS, Zipursky A. Assessment of anemia in newborn infants. Clin Perinatol 1995; 22: 657–69

    Google Scholar 

  64. Ramasethu J, Luban NLC. Red blood cell transfusions in the newborn. Semin Neonatol 1999; 4: 5–16

    Article  Google Scholar 

  65. Gorodischer R, Burtin P, Hwang P, et al. Saliva versus blood sampling for therapeutic drug monitoring in children: patient and parental preferences and an economic analysis. Ther Drug Monit 1994; 16: 437–43

    Article  PubMed  CAS  Google Scholar 

  66. Lee TC, Charles BG, Steer PA, et al. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity. Ther Drug Monit 1996; 18: 288–93

    Article  PubMed  CAS  Google Scholar 

  67. Khanna NN, Bada HS, Somani SM. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants. J Pediatr 1980; 96: 494–9

    Article  PubMed  CAS  Google Scholar 

  68. Walther FJ, Erickson R, Sims ME. Cardiovascular effects of caffeine therapy in preterm infants. Am J Dis Child 1990; 144: 1164–6

    PubMed  CAS  Google Scholar 

  69. Dani C, Bertini G, Reali MF, et al. Brain hemodynamic changes in preterm infants after maintenance dose caffeine and aminophylline treatment. Biol Neonate 2000; 78: 27–32

    Article  PubMed  CAS  Google Scholar 

  70. Lundstrom KE, Larsen PB, Brendstrup L, et al. Cerebral blood flow and left ventricular output in spontaneously breathing newborn preterm infants treated with caffeine or theophylline. Acta Paediatr 1995; 84: 6–9

    Article  PubMed  CAS  Google Scholar 

  71. Saliba E, Autret E, Gold F, et al. Effect of caffeine on cerebral blood flow velocity in preterm infants. Biol Neonate 1989; 56: 198–203

    Article  PubMed  CAS  Google Scholar 

  72. McDonnell M, Ives NK, Hope PL. Intravenous aminophylline and cerebral blood flow in preterm infants. Arch Dis Child 1992; 67: 416–8

    Article  PubMed  CAS  Google Scholar 

  73. Robinson MJ, Clayden GS, Smith MF. Xanthines and necrotizing enterocolitis. Arch Dis Child 1980; 55: 494–5

    Article  PubMed  CAS  Google Scholar 

  74. Davis JM, Abbasi S, Spitzer AR, et al. Role of theophylline in pathogenesis of necrotizing enterocolitis. J Pediatr 1986; 109: 344–6

    Article  PubMed  CAS  Google Scholar 

  75. Lane AJP, Coombs RC, Evans DH, et al. Effect of caffeine on splanchnic blood flow. Arch Dis Child Fetal Neonatal Ed 1999; 80: 128–29F

    Article  Google Scholar 

  76. Grosfeld JL, Dalsing MC, Hull M, et al. Neonatal apnea, xanthines, and necrotizing enterocolitis. J Pediatr Surg 1983; 18: 80–84

    Article  PubMed  CAS  Google Scholar 

  77. Kosloske A. Pathogenesis and prevention of necrotizing enterocolitis: ahypothesis based on personal observation and a review of the literature. Pediatrics 1984; 74: 1086–92

    PubMed  CAS  Google Scholar 

  78. Gillot I, Gouyon JB, Guignard JP. Renal effects of caffeine in preterm infants. Biol Neonate 1990; 58: 133–6

    Article  PubMed  CAS  Google Scholar 

  79. Zanardo V, Dani C, Trevisanuto D, et al. Methylxanthines increase renal calcium excretion in preterm infants. Biol Neonate 1995; 68: 169–74

    Article  PubMed  CAS  Google Scholar 

  80. Mazkereth R, Laufer J, Jordan S, et al. Effects of theophylline on renal function in premature infants. Am J Perinatol 1997; 14: 45–9

    Article  PubMed  CAS  Google Scholar 

  81. Wardrop CAJ, Holland BM, Veale KEA, et al. Non-physiologic anemia of prematurity. Arch Dis Child 1978; 53: 855–60

    Article  PubMed  CAS  Google Scholar 

  82. Bakris G, Sauter ER, Hussey JL, et al. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplant. N Engl J Med 1990; 323: 86–90

    Article  PubMed  CAS  Google Scholar 

  83. Fang S, Sherwood RA, Gamsu HR, et al. Comparison of the effects of theophylline and caffeine on serum erythropoetin concentration in premature infants. Eur J Paediatr 1998; 157: 406–9

    Article  CAS  Google Scholar 

  84. Carnielli VP, Verlato G, Benini F, et al. Metabolic and respiratory effects of theophylline in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2000; 83: F39–43

    Article  PubMed  CAS  Google Scholar 

  85. Bauer J, Maier K, Linderkamp O, et al. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics 2001; 107: 660–3

    Article  PubMed  CAS  Google Scholar 

  86. Diderholm B, Ewald U, Gustafsson J. Effect of theophylline on glucose production and lipolysis in pretrm infants (≤32 weeks). Pediatr Res 1999; 45: 674–9

    Article  PubMed  CAS  Google Scholar 

  87. Vandenplas Y, De Wolf D, Sacre L. Influence of xanthines on gastroesophageal reflux in infants at risk of sudden infant death syndrome. Pediatrics 1986; 77: 807–10

    PubMed  CAS  Google Scholar 

  88. American Academy of Pediatrics policy statement. Precautions concerning the use of theophylline. Pediatrics 1992; 89: 781–3

    Google Scholar 

  89. Banner W, Czajka PA. Acute caffeine overdose in the neonate. Am J Dis Child 1980; 134: 495–8

    PubMed  Google Scholar 

  90. Kulkarni PB, Dorand RD. Caffeine toxicity in a neonate. Pediatrics 1979; 64: 254–5

    PubMed  CAS  Google Scholar 

  91. van den Anker JN, Jongejan HT, Sauer PJ. Severe caffeine intoxication in a preterm neonate. Eur J Paediatr 1992; 151: 466–7

    Article  Google Scholar 

  92. Davis PG, Doyle LW, Rickards AL, et al. Methylxanthines and sensorineural outcome at 14 years in children <1501g birthweight. J Paediatr Child Health 2000; 36: 47–50

    Article  PubMed  CAS  Google Scholar 

  93. Le Guennec JC, Sitruk F, Breault C, et al. Somatic growth in infants receiving prolonged caffeine therapy. Acta Paediatr Scand 1990; 79: 52–6

    Article  PubMed  Google Scholar 

  94. Perrin C, Debruyne D, Lacotte J, et al. Treatment of caffeine intoxication by exchange transfusion in the newborn. Acta Paediatr Scand 1987; 76: 679–81

    Article  PubMed  CAS  Google Scholar 

  95. Ernberg A, Leff RD, Haack DG, et al. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy 2000; 20: 644–52

    Article  Google Scholar 

  96. Romangoli C, De Carolis MP, Muzzi U, et al. Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants. Ther Drug Monit 1992; 14: 14–9

    Article  Google Scholar 

  97. Anwar M, Mondestin H, Mojica N, et al. Effect of caffeine on pneumogram and apnoea of infancy. Arch Dis Child 1986; 61: 891–5

    Article  PubMed  CAS  Google Scholar 

  98. Murat I, Moriette G, Blin MC, et al. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 1981; 99: 984–9

    Article  PubMed  CAS  Google Scholar 

  99. Aranda JV, Gorman W, Bergsteinsson H, et al. Efficacy of caffeine in the treatment of apnea in the low-birth-weight infant. J Pediatr 1977; 90: 467–72

    Article  PubMed  CAS  Google Scholar 

  100. Amato M, Isenschmid M, Huppi P. Percutaneous caffeine application in the treatment of neonatal apnoea. Eur J Paediatr 1991; 150: 592–4

    Article  CAS  Google Scholar 

  101. Gupta JM, Mercer HO, Koo WWK. Theophylline in treatment of apnea of prematurity. Aust Paediatr J 1981; 17: 290–1

    PubMed  CAS  Google Scholar 

  102. Sims ME, Yau G, Ranbhatla S, et al. Limitations of theophylline in the apnea of prematurity. Am J Dis Child 1985; 139: 567–70

    PubMed  CAS  Google Scholar 

  103. Uauy R, Shapiro DL, Smith B, et al. Treatment of severe apnea in prematures with orally administered theophylline. Pediatrics 1975; 55: 595–8

    PubMed  CAS  Google Scholar 

  104. Shannon DC, Gotay F, Stein IM, et al. Prevention of apnea and bradycardia in low-birthweight infants. Pediatrics 1975; 55: 589–94

    PubMed  CAS  Google Scholar 

  105. Brouard C, Moriette D, Murat I, et al. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants. Am J Dis Child 1985; 139: 698–700

    PubMed  CAS  Google Scholar 

  106. Bairam A, Boutroy MJ, Badonnel Y, et al. Theophylline vs caffeine: comparative effects in the treatment of idiopathic apnea in the preterm infant. J Pediatr 1987; 110: 636–8

    Article  PubMed  CAS  Google Scholar 

  107. Scanlon JEM, Chin KC, Morgan MEI, et al. Caffeine or theophylline for neonatal apnoea. Arch J Dis Child 1992; 67: 425–8

    Article  CAS  Google Scholar 

  108. Larsen PB, Brendstrup L, Skov L, et al. Aminophylline vs caffeine citrate for apnea and bradycardia prophylaxis in premature neonates. Acta Paediatr 1995; 84: 360–4

    Article  PubMed  CAS  Google Scholar 

  109. Peliowski A, Finer NN. Blinded, randomized, placebo-controlled, trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr 1990; 116: 648–53

    Article  PubMed  CAS  Google Scholar 

  110. Eyal F, Alpan G, Sagi E, et al. Aminophylline vs doxapram in idiopathic apnea of prematurity. Pediatrics 1985; 75: 709–13

    PubMed  CAS  Google Scholar 

  111. Bopp P, Drummond G, Fisher J, et al. Effect of doxapram on control of breathing in cats. Can Anaesth Soc J 1979; 26: 191–5

    Article  PubMed  CAS  Google Scholar 

  112. Mitchell RA, Herbert DA. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology 1975; 42: 559–66

    Article  PubMed  CAS  Google Scholar 

  113. Edwards G, Leszczynski SO. A double blind trial of five respiratory stimulants in patients with acute ventilatory failure. Lancet 1967; II: 226–9

    Article  Google Scholar 

  114. Calverley PMA, Robson RH, Wraith PK, et al. The ventilatory effects of doxapram in normal man. Clin Sci (Lond) 1983; 65: 65–9

    CAS  Google Scholar 

  115. Scott RM, Whitwam JG, Chakrabarti MK. Evidence of a role for chemoreceptors in the ventilatory response to doxapram in man. Br J Anaesth 1977; 49: 227–31

    Article  PubMed  CAS  Google Scholar 

  116. Barrington KJ, Finer NN, Peters KL, et al. Physiologic effects of doxapram in idiopathic apnea of prematurity. J Pediatr 1986; 108: 125–9

    Google Scholar 

  117. Jamali F, Barrington KJ, Finer NN, et al. Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Dev Pharmacol Ther 1988; 11: 253–7

    PubMed  CAS  Google Scholar 

  118. Hayakawa F, Hakamada S, Kuno K, et al. Doxapram in the treatment of idiopathic apnea of prematurity: desirable dosage and serum concentrations. J Pediatr 1986; 109: 138–40

    Article  PubMed  CAS  Google Scholar 

  119. Barrington KJ, Finer NN, Torok-Both G, et al. Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics 1987; 80: 22–7

    PubMed  CAS  Google Scholar 

  120. Beaudry MA, Bradley JM, Gramlich LM, et al. Pharmacokinetics of doxapram in idiopathic apnea of pematurity. Dev Pharmacol Ther 1988; 11: 65–72

    PubMed  CAS  Google Scholar 

  121. Bairam A, Blanchard PW, Mullahoo K, et al. Pharmacodynamic effects and pharmacokinetic profiles of keto-doxapram and doxapram in newborn lambs. Pediatr Res 1990; 28: 142–6

    PubMed  CAS  Google Scholar 

  122. Bairam A, Branchaud C, Beharry K, et al. Doxapram metabolism in human fetal hepatic organ culture. Clin Pharmacol Ther 1991; 50: 32–8

    Article  PubMed  CAS  Google Scholar 

  123. Alpan G, Eyal F, Sagi E, et al. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline. J Pediatr 1984; 104: 634–7

    Article  PubMed  CAS  Google Scholar 

  124. Sagi E, Eyal F, Alpan G, et al. Idiopathic apnoea of prematurity treated with doxapram and aminophylline. Arch Dis Child 1984; 59: 281–3

    Article  PubMed  CAS  Google Scholar 

  125. Yamazaki T, Kajiwara M, Itahashi K, et al. Low-dose doxapram therapy for idiopathic apnea of prematurity. Pediatr Int 2001; 43: 124–7

    Article  PubMed  CAS  Google Scholar 

  126. Barrington KJ, Muttitt SC. Randomized, controlled, blinded trial of doxapram for extubation of the very low birthweight infant. Acta Paediatr 1998; 87: 191–4

    Article  PubMed  CAS  Google Scholar 

  127. Bairam A, Faulon M, Monin P, et al. Doxapram for the initial treatment of apnea of prematurity. Biol Neonate 1992; 61: 209–13

    Article  PubMed  CAS  Google Scholar 

  128. Tay-Uyboco J, Kwiatkowski K, Cates DB, et al. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate 1991; 59: 190–200

    Article  PubMed  CAS  Google Scholar 

  129. Poets C, Darraj S, Bohnhorst B. Effects of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. Biol Neonate 1990; 76: 207–13

    Article  Google Scholar 

  130. Huon C, Rey E, Mussat P, et al. Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: a randomized, double-blind study. Acta Paediatr 1998; 87: 1180–4

    Article  PubMed  CAS  Google Scholar 

  131. Fancourt GJ, Aston RJ, Talbot IC, et al. Hepatic necrosis with doxapram hydrochloride. Postgrad Med J 1985; 61: 833–5

    Article  PubMed  CAS  Google Scholar 

  132. De Villiers GS, Walele A, Van Der Marwe PL, et al. Second-degree atrioventricular heart block after doxapram administration. J Pediatr 1998; 133: 149–50

    Article  PubMed  Google Scholar 

  133. Hunt CE, Inwood RJ, Shannon DC, et al. Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. Am Rev Resp Dis 1979; 119: 263–9

    PubMed  CAS  Google Scholar 

  134. Barbe F, Hansen C, Badonnel Y, et al. Severe side effects and drug plasma concentrations in preterm infants treated with doxapram. Ther Drug Monit 1999; 21: 547–52

    Article  PubMed  CAS  Google Scholar 

  135. Sreenan C, Etches PC, Demianczuk N, et al. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea. J Pediatr 2001; 139: 832–7

    Article  PubMed  CAS  Google Scholar 

  136. Finer NN, Barrington KJ, Hayes BJ, et al. Obstructive, mixed, and central apnea in the neonate: physiologic correlates. J Pediatr 1992; 121(6): 943–50

    Article  PubMed  CAS  Google Scholar 

  137. Rigatto H, Brady JP. Periodic breathing and apnea in preterm infants (II): hypoxia as a primary event. Pediatrics 1972; 50(2): 219–28

    PubMed  CAS  Google Scholar 

  138. Fenner A, Schalk U, Hoenicke H, et al. Periodic breathing in premature and neonatal babies: incidence, breathing pattern, respiratory gas tensions, response to changes in the composition of ambient air. Pediatr Res 1973; 7(4): 174–83

    Article  PubMed  CAS  Google Scholar 

  139. Weintraub Z, Alvaro R, Kwiatkowski K, et al. Effects of inhaled oxygen (up to 40%) on periodic breathing and apnea in preterm infants. J Appl Physiol 1992; 72(1): 116–20

    PubMed  CAS  Google Scholar 

  140. Blank JP, Sheagren TG, Vajaria J, et al. The role of RBC transfusion in the premature infant. Am J Dis Child 1984; 138(9): 831–3

    PubMed  CAS  Google Scholar 

  141. Joshi A, Gerhardt T, Shandloff P, et al. Blood transfusion effect on the respiratory pattern of preterm infants. Pediatrics 1987; 80(1): 79–84

    PubMed  CAS  Google Scholar 

  142. DeMaio JG, Harris MC, Deuber C, et al. Effect of blood transfusion on apnea frequency in growing premature infants. J Pediatr 1989; 114(6): 1039–41

    Article  PubMed  CAS  Google Scholar 

  143. Stute H, Greiner B, Linderkamp O. Effect of blood transfusion on cardiorespiratory abnormalities in preterm infants. Arch Dis Child Fetal Neonatal Ed 1995; 72(3): F194–6

    Article  PubMed  CAS  Google Scholar 

  144. Poets CF, Pauls U, Bohnhorst B. Effect of blood transfusion on apnoea, bradycardia and hypoxaemia in preterm infants. Eur J Pediatr 1997; 156(4): 311–6

    Article  PubMed  CAS  Google Scholar 

  145. Heimler R, Langlois J, Hodel DJ, et al. Effect of positioning on the breathing pattern of preterm infants. Arch Dis Child 1992; 67(3): 312–4

    Article  PubMed  CAS  Google Scholar 

  146. Kurlak LO, Ruggins NR, Stephenson TJ. Effect of nursing position on incidence, type, and duration of clinically significant apnoea in preterm infants. Arch Dis Child Fetal Neonatal Ed 1994; 71(1): F16–9

    Article  PubMed  CAS  Google Scholar 

  147. Keene DJ, Wimmer Jr JE, Mathew OP. Does supine positioning increase apnea, bradycardia, and desaturation in preterm infants. J Perinatol 2000; 20(1): 17–20

    Article  PubMed  CAS  Google Scholar 

  148. Jenni OG, von Siebenthal K, Wolf M, et al. Effect of nursing in the head elevated tilt position (15 degrees) on the incidence of bradycardic and hypoxemic episodes in preterm infants. Pediatrics 1997; 100(4): 622–5

    Article  PubMed  CAS  Google Scholar 

  149. van Someren V, Linnett SJ, Stothers JK, et al. An investigation into the benefits of resiting nasoenteric feeding tubes. Pediatrics 1984; 74(3): 379–83

    PubMed  Google Scholar 

  150. Henderson-Smart DJ, Osborn DA. Kinesthetic stimulation for preventing apnea in preterm infants. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2002

    Google Scholar 

  151. Osborn DA, Henderson-Smart DJ. Kinesthetic stimulation for treating apnea in preterm infants (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2002

    Google Scholar 

  152. Korner AF, Kraemer HC, Haffner ME, et al. Effects of waterbed flotation on premature infants: a pilot study. Pediatrics 1975; 56(3): 361–7

    PubMed  CAS  Google Scholar 

  153. Tuck SJ, Monin P, Duvivier C, et al. Effect of a rocking bed on apnoea of prematurity. Arch Dis Child 1982; 57(6): 475–7

    Article  PubMed  CAS  Google Scholar 

  154. Jirapaet K. The effect of vertical pulsating stimulation on apnea of prematurity. J Med Assoc Thai 1993; 76(6): 319–26

    PubMed  CAS  Google Scholar 

  155. Henderson-Smart DJ, Subramanian P, Davis PG. Continuous positive airway pressure versus theophylline for apnea in preterm infants (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2000: CD001072

    Google Scholar 

  156. Speidel BD, Dunn PM. Use of nasal continuous positive airway pressure to treat severe recurrent apnoea in very preterm infants. Lancet 1976; II(7987): 658–60

    Article  Google Scholar 

  157. Kattwinkel J, Nearman HS, Fanaroff AA, et al. Apnea of prematurity: comparative therapeutic effects of cutaneous stimulation and nasal continuous positive airway pressure. J Pediatr 1975; 86(4): 588–92

    Article  PubMed  CAS  Google Scholar 

  158. Miller MJ, Carlo WA, Martin RJ. Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants. J Pediatr 1985; 106(1): 91–4

    Article  PubMed  CAS  Google Scholar 

  159. Sreenan C, Lemke RP, Hudson-Mason A, et al. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 2001; 107(5): 1081–3

    Article  PubMed  CAS  Google Scholar 

  160. Daily WJ, Klaus M, Meyer HB. Apnea in premature infants: monitoring, incidence, heart rate changes, and an effect of environmental temperature. Pediatrics 1969; 43(4): 510–8

    PubMed  CAS  Google Scholar 

  161. Perlstein PH, Edwards NK, Sutherland JM. Apnea in premature infants and incubator-air-temperature changes. N Engl J Med 1970; 282(9): 461–6

    Article  PubMed  CAS  Google Scholar 

  162. Berterottiere D, D’Allest AM, Dehan M, et al. Effects of increase in body temperature on the breathing pattern in premature infants. J Dev Physiol 1990; 13(6): 303–8

    PubMed  CAS  Google Scholar 

  163. Belgaumkar TK, Scott KE. Effects of low humidity on small premature infants in servo control incubators (II): increased severity of apnea. Biol Neonate 1975; 26(5–6): 348–52

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No outside sources of funding were used in the preparation/development of this manuscript and the authors have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Clinical Sciences, College of Pharmacy, University of Michigan, F5203, 200 East Hospital Drive, Ann Arbor, Michigan, 48109, USA

    Varsha Bhatt-Mehta

  2. Department of Pediatrics and Communicable Disease, Medical School, University of Michigan, Ann Arbor, Michigan, USA

    Varsha Bhatt-Mehta & Robert E. Schumacher

Authors
  1. Varsha Bhatt-Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert E. Schumacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhatt-Mehta, V., Schumacher, R.E. Treatment of Apnea of Prematurity. Pediatr-Drugs 5, 195–210 (2003). https://doi.org/10.2165/00128072-200305030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128072-200305030-00006

Keywords

Search

Navigation